MICHAEL CORBAT, a director at $CB, bought 425 shares of the company on 07-25-2025 for an estimated $114,665. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 21.0%. Following this trade, they now own 2,450 shares of this class of $CB stock.
$CB Insider Trading Activity
$CB insiders have traded $CB stock on the open market 20 times in the past 6 months. Of those trades, 2 have been purchases and 18 have been sales.
Here’s a breakdown of recent trading of $CB stock by insiders over the last 6 months:
- JOHN W KEOGH (President & COO) has made 1 purchase buying 9,809 shares for an estimated $2,874,135 and 4 sales selling 94,876 shares for an estimated $27,563,599.
- JOSEPH F WAYLAND (Executive Vice President and*) has made 0 purchases and 3 sales selling 27,492 shares for an estimated $8,017,858.
- EVAN G GREENBERG (Chairman & CEO) has made 0 purchases and 2 sales selling 25,728 shares for an estimated $7,498,397.
- TIMOTHY ALAN BOROUGHS (Executive Vice President*) has made 0 purchases and 3 sales selling 14,748 shares for an estimated $4,367,248.
- JUAN LUIS ORTEGA (Executive Vice President*) sold 6,504 shares for an estimated $1,900,013
- JOHN J LUPICA (Vice Chrm, Chubb Group*) has made 0 purchases and 2 sales selling 5,513 shares for an estimated $1,599,077.
- GEORGE F. OHSIEK (Chief Accounting Officer) has made 0 purchases and 2 sales selling 1,770 shares for an estimated $491,086.
- MICHAEL G ATIEH sold 538 shares for an estimated $154,707
- MICHAEL CORBAT purchased 425 shares for an estimated $114,665
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CB Hedge Fund Activity
We have seen 855 institutional investors add shares of $CB stock to their portfolio, and 849 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GQG PARTNERS LLC added 4,964,298 shares (+112.1%) to their portfolio in Q1 2025, for an estimated $1,499,168,353
- GAMMA INVESTING LLC removed 2,075,738 shares (-99.6%) from their portfolio in Q2 2025, for an estimated $601,382,813
- VIKING GLOBAL INVESTORS LP added 1,949,065 shares (+inf%) to their portfolio in Q1 2025, for an estimated $588,598,139
- PRICE T ROWE ASSOCIATES INC /MD/ removed 1,832,443 shares (-11.2%) from their portfolio in Q1 2025, for an estimated $553,379,461
- ONTARIO TEACHERS PENSION PLAN BOARD removed 1,423,181 shares (-99.9%) from their portfolio in Q1 2025, for an estimated $429,786,430
- WELLINGTON MANAGEMENT GROUP LLP removed 1,364,749 shares (-16.0%) from their portfolio in Q1 2025, for an estimated $412,140,550
- CASTLEKEEP INVESTMENT ADVISORS LLC removed 1,215,076 shares (-99.6%) from their portfolio in Q1 2025, for an estimated $366,940,801
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CB Congressional Stock Trading
Members of Congress have traded $CB stock 6 times in the past 6 months. Of those trades, 1 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $CB stock by members of Congress over the last 6 months:
- REPRESENTATIVE JOSH GOTTHEIMER purchased up to $15,000 on 06/13.
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 06/13.
- REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 05/12.
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 04/07, 02/14.
- REPRESENTATIVE GEORGE WHITESIDES sold up to $250,000 on 03/24.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CB Analyst Ratings
Wall Street analysts have issued reports on $CB in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Keefe, Bruyette & Woods issued a "Outperform" rating on 07/09/2025
- Barclays issued a "Overweight" rating on 04/11/2025
- RBC Capital issued a "Outperform" rating on 01/30/2025
To track analyst ratings and price targets for $CB, check out Quiver Quantitative's $CB forecast page.
$CB Price Targets
Multiple analysts have issued price targets for $CB recently. We have seen 9 analysts offer price targets for $CB in the last 6 months, with a median target of $304.0.
Here are some recent targets:
- Elyse Greenspan from Wells Fargo set a target price of $267.0 on 07/24/2025
- Paul Newsome from Piper Sandler set a target price of $283.0 on 07/24/2025
- Meyer Shields from Keefe, Bruyette & Woods set a target price of $324.0 on 07/09/2025
- Alex Scott from Barclays set a target price of $298.0 on 07/07/2025
- Michael Phillips from Morgan Stanley set a target price of $300.0 on 05/19/2025
- Brian Meredith from UBS set a target price of $304.0 on 04/28/2025
- Yaron Kinar from Jefferies set a target price of $308.0 on 04/11/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
